These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2189381)

  • 61. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.
    Allen DC; Foster H; Orchin JC; Biggart JD
    J Clin Pathol; 1987 Feb; 40(2):157-62. PubMed ID: 3546394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
    Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
    Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Telomerase activity in premalignant and malignant lesions of human oral mucosa.
    Kannan S; Tahara H; Yokozaki H; Mathew B; Nalinakumari KR; Nair MK; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):413-20. PubMed ID: 9184774
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M
    Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential expression of multidrug resistance gene product, P-glycoprotein, in normal, dysplastic and malignant oral mucosa in India.
    Jain V; Das SN; Luthra K; Shukla NK; Ralhan R
    Int J Cancer; 1997 Feb; 74(1):128-33. PubMed ID: 9036881
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Localization of H-ras mRNA in oral squamous cell carcinomas.
    Hoellering J; Shuler CF
    J Oral Pathol Med; 1989 Feb; 18(2):74-8. PubMed ID: 2664134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma.
    Field JK; Yiagnisis M; Spandidos DA; Gosney JR; Papadimitriou K; Vaughan ED; Stell PM
    Eur J Surg Oncol; 1992 Apr; 18(2):168-76. PubMed ID: 1582509
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of RARalpha and RARbeta in human oral potentially malignant and neoplastic lesions.
    Chakravarti N; Mathur M; Bahadur S; Shukla NK; Rochette-Egly C; Ralhan R
    Int J Cancer; 2001 Jan; 91(1):27-31. PubMed ID: 11149416
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
    Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
    Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
    Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
    Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.
    Shabana AH; Ivanyi L; Kramer IR
    Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
    Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
    Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Studies on ras P21 expression and mutation at 12th codon of C-Ha-ras oncogene in squamous cell carcinoma of the larynx].
    Yang Q
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(4):209-12, 251. PubMed ID: 8167038
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Prostacyclin (PGI2) biosynthetic activity in variously differentiated neoplasms and the surrounding tissue].
    Schulz S; Mentz P; Timmel H; Giessler C
    Zahn Mund Kieferheilkd Zentralbl; 1989; 77(8):811-4. PubMed ID: 2534016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma.
    Mishima K; Yamada E; Masui K; Shimokawara T; Takayama K; Sugimura M; Ichijima K
    Mod Pathol; 1998 Sep; 11(9):886-91. PubMed ID: 9758369
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of normal and mutant ras proteins in human acute leukemia.
    Shen WP; Aldrich TH; Venta-Perez G; Franza BR; Furth ME
    Oncogene; 1987 May; 1(2):157-65. PubMed ID: 3325880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.